| Zhang, Jianyong |
NCT04934059: Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS). |
|
|
| Not yet recruiting | 4 | 60 | RoW | Yuxuebi tablet, Placebo tablet | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | Ankylosing Spondylitis | 01/22 | 01/22 | | |
NCT04683406: A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A |
|
|
| Completed | 3 | 750 | RoW | ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral), Placebo to ZSP1273 | Guangdong Raynovent Biotech Co., Ltd | Influenza A | 04/23 | 05/23 | | |
ORIENT, NCT05401071: Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) |
|
|
| Recruiting | 2/3 | 2442 | RoW | Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with Rifapentine 15mg/kg, Short Regimen with Rifapentine 20mg/kg | Huashan Hospital | Tuberculosis, Pulmonary | 10/24 | 11/27 | | |
NCT03787940: Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis |
|
|
| Recruiting | N/A | 676 | RoW | Isoniazid | Beijing Chest Hospital | Tuberculous Meningitis | 12/21 | 12/21 | | |
| Recruiting | N/A | 10000 | RoW | Installation or registration of smartphone application | Chinese Alliance Against Lung Cancer | Solitary Pulmonary Nodule | 10/25 | 10/25 | | |
INSPIRE-TB, NCT05081401: Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis |
|
|
| Recruiting | N/A | 3000 | RoW | This is a non-intervention observational study. | Huashan Hospital | Multidrug Resistant Tuberculosis | 12/25 | 12/25 | | |
